Cassava Sciences
Stock Forecast, Prediction & Price Target
Cassava Sciences Financial Estimates
Cassava Sciences Revenue Estimates
Cassava Sciences EBITDA Estimates
Cassava Sciences Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $-1.8K 0% | $0 100% | Avg: $100M Low: $100M High: $100M avg. 0% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $6.4M Low: $6.4M High: $6.4M avg. 0% | Avg: $72.4M Low: $72.4M High: $72.4M avg. 1031.25% |
Net Income
% change YoY
| $-31.80M N/A | $-72.47M -127.88% | $-97.21M -34.14% | Avg: $17.75M Low: $-38.15M High: $68.34M avg. 118.25% | Avg: $-67.2M Low: $-50.31M High: $-50.31M avg. -478.59% | Avg: $-31.86M Low: $-31.86M High: $-31.86M avg. 52.57% | Avg: $10.90M Low: $10.90M High: $10.90M avg. 134.21% |
EBITDA
% change YoY
| $-32.86M N/A | $-80.02M -143.45% | $-95.68M -19.57% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$0.81 N/A | -$1.8 -122.22% | -$2.32 -28.88% | Avg: $0.36 Low: -$0.91 High: $1.63 avg. 115.51% | Avg: -$1.2 Low: -$1.2 High: -$1.2 avg. -433.33% | Avg: -$0.76 Low: -$0.76 High: -$0.76 avg. 36.66% | Avg: $0.26 Low: $0.26 High: $0.26 avg. 134.21% |
Operating Expenses
% change YoY
| $32.86M N/A | $80.02M 143.45% | $105.95M 32.41% | Avg: $-133.12B Low: $-133.12B High: $-133.12B avg. -125735.87% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $-8.51B Low: $-8.51B High: $-8.51B avg. 0% | Avg: $-96.37B Low: $-96.37B High: $-96.37B avg. -1031.25% |
FAQ
What is Cassava Sciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -43.38% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -38.15M, average is 17.75M and high is 68.34M.
What is Cassava Sciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 257.81% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $100M, average is $100M and high is $100M.
What is Cassava Sciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -36.73% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.91, average is $0.36 and high is $1.63.